Best Retina Today Podcasts (2024)

1
ASRS Leaders and Legends Interview: Mark S. Blumenkranz, MD 32:20

1d ago32:20

32:20

The History of Retina is pleased to share this Leaders & Legends interview featuring the extraordinary life and career of Mark Blumenkranz, MD. Dr. Blumenkranz is the HU Smead Professor Emeritus and co-director of the Ophthalmic Innovation Program at the Byers Eye Institute at Stanford University School of Medicine. In addition, he serves as manage…

1
ASRS Leaders and Legends Interview: Emily Y. Chew, MD 27:54

1d ago27:54

27:54

Emily Y. Chew, MD, is director of the Division of Epidemiology and Clinical Applications and deputy clinical director of the National Eye Institute (NEI). She is also a senior investigator and Chief of the NEI’s Clinical Trials Branch. In this Leaders & Legends interview Dr. Chew shares fascinating experiences and perspectives from her extraordinar…

1
ASRS Leaders and Legends Interview: Eugene de Juan, Jr., MD, FASRS 29:41

1d ago29:41

29:41

Unlike most kids, Eugene de Juan, Jr., preferred his toys broken. Fascinated by his ophthalmologist father’s many gadgets and his grandfather’s workshop, Gene discovered his passion for fixing things at an early age. He went on to complete his ophthalmology and vitreoretinal training at world-class institutions including the Johns Hopkins Universit…

1
Celebrating 400 Episodes of OIS 53:41

1d ago53:41

53:41

Discover the milestone 400th episode of the OIS podcast with Dr. Firas Rahhal and Dr. Robert Rothman, where they explore the impact of Ophthalmology Innovation Summit (OIS) on the investment ecosystem: Journey of OIS Rich Insights Collaboration Clinical Mastery Long-Term Relationships Humor and Admiration Future of Ophthalmology Tune in to this epi…

1
From Trials to the Clinic: Using a Therapy With a Novel MOA to Treat Patients With DME 29:41

2d ago29:41

29:41

One of the challenges associated with current anti-VEGF therapies for the management of DME is the need for frequent injections and the potential impact on adherence and vision outcomes. Join Dr. John Kitchens and Dr. Maria Berrocal as they share their experiences treating their DME patients using a therapy with a novel mechanism of action, and how…

1
New Retina Radio Journal Club w/ VBS: RVOs During the COVID Pandemic 15:15

17d ago15:15

15:15

What did a review of the AAO IRIS Registry reveal about the rates of retinal vein occlusion (RVO) during the COVID-19 pandemic? Moderator Katherine Talcott, MD, sits down with Phoebe Mellen, MD, and Kyle Kovacs, MD, to review the study's conclusion that RVO rates did not increase during the pandemic, discuss challenges about talking to patients see…

1
Advances in Corneal Health 8:33

22d ago8:33

8:33

In this episode of Eye on Innovation Podcast, Carey Powers delves into the latest advancements in corneal crosslinking technology with expert guest Dr. Deepinder Dhaliwal. Dr. Dhaliwal, a renowned professor of ophthalmology at the University of Pittsburgh School of Medicine and director of refractive surgery at the UPMC Vision Institute, shares her…

1
A Treatment With a Novel MOA for Patients With nAMD and DME: Perspectives From the Real World 34:24

24d ago34:24

34:24

Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patien…

1
AMD and DME Applications in the Retina Practice: Real-world Data 21:08

27d ago21:08

21:08

In the second episode of this 2-part series, moderator Paul Hahn, MD, PhD, and panelists Durga Borkar, MD, MMCi, and Ted Leng, MD, turn to the findings of FARETINA-AMD and FARETINA-DME, which rely on real-world outcomes as documented in the AAO IRIS Registry. What can retina specialists learn from these studies, and how might these studies' finding…

1
Revolutionizing Eye Care 41:10

1M ago41:10

41:10

In our latest episode, host Dr. Rob Rothman interviews Greg Kunst, CEO of Aurion Biotech, to delve into the forefront of cell therapy for corneal disease. Join us to discover: Greg's journey from pivotal roles at Alcon and Glaukos to leading Aurion Biotech The innovative allogenic cell therapy technology developed by Aurion How this technology addr…

1
The MSO Model You Have Never Heard Of with Will Vanderveer of Redefine Healthcare 19:29

1M ago19:29

19:29

This is the Healthcare Executive Insights Podcast presented by The Macallan Group. In this episode, we speak with Will Vanderveer, CEO at Redefine Healthcare, and explore how Redefine Healthcare is revolutionizing the landscape for independent physicians. Unlike traditional management service organizations (MSOs), Redefine Healthcare operates witho…

1
ARVO 2024 Coverage: UWF Leakage in Protocol AA, Machine Learning, and GA's Link to Anxiety/Depression 22:55

1M ago22:55

22:55

Protocol AA might be complete—but analysis of its data is far from over. What did that study’s data tell us about the relationship between leakage and DR severity? Justis Ehlers, MD, breaks down what he and his team uncovered when examining ultra-widefield images from Protocol AA, and helps us understand how machine learning might be used in future…

1
New Retina Radio Journal Club with VBS: New Retina Radio Journal Club with VBS: Is Buckling Effective for RRD in Patients at Risk for PVR? 13:57

2M ago13:57

13:57

How do outcomes differ for RRD patients at risk of PVR following PPV alone or combined PPV/scleral buckling? Moderator David Xu, MD, hears from panelists Barton Blackorby, MD, and Prethy Rao, MD, MPH, about a recent peer-reviewed paper published in Ophthalmology Retina covering surgical outcomes of patients with RRD who were considered high risk fo…

1
Todays Therapies are Not Sufficient: A Marketplace Ripe for Innovation 36:58

2M ago36:58

36:58

This week's OIS Podcast features a compelling panel discussion from the Dry Horizons Symposium co-presented by Ora and OIS, held on May 3 in Seattle. The panel, comprising leading experts in ophthalmology and dry eye research, covered essential topics in the field: 🔹Advancements in Diagnostics: Insights into new tools and technologies for more accu…

1
ARVO 2024 Coverage: ≥20-week Dosing in PULSAR and TENAYA/LUCERNE 16:00

2M ago16:00

16:00

Could next-generation anti-VEGF agents such as faricimab (Vabysmo, Genentech/Roche) and high-dose aflibercept (Eylea HD, Regeneron) be dosed as infrequently as every 20 weeks without sacrificing efficacy? And even if there are data that suggest that finding, would anyone actually adopt an interval that long in wet AMD patients? Philip Storey, MD, f…

1
ASRS Leaders and Legends Interview: Drs. Susan B. and Neil M. Bressler 39:46

2M ago39:46

39:46

Leaders & Legends is pleased to share an interview with a true dynamic duo in retina: Drs. Susan and Neil Bressler. Susan and Neil’s personal and professional partnership started in their early days at John Hopkins medical school and, with thoughtful intention, they set out to build their life and careers together. They both pursued ophthalmology r…

1
AI and Robotics Transforming Retina Medicine 13:50

2M ago13:50

13:50

Explore the cutting-edge world of ophthalmology with the Eye on Innovation Podcast. In the latest episode, Carey Powers hosts Dr. Rishi Singh and Dr. Michael Singer as they delve into how AI and robotics are transforming retina medicine, bringing unprecedented changes to diagnosis, clinical trials, and patient care. This insightful discussion provi…

1
GA Options in Clinical Therapy, Part 2: Real-world Cases in GA 17:20

2M ago17:20

17:20

David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, return for the second episode in this podcast miniseries, in which they review a trio of real-world GA cases, explore what early responses to treatment look like, and ask how to address GA in the presence of wet AMD.By Retina Today

1
GA Options in Clinical Therapy, Part 1: Patient Selection and Treatment Strategies 23:42

2M ago23:42

23:42

Join David RP Almeida, MD, PhD, MBA; Lisa Faia, MD; and Chris Riemann, MD, as they assess which clinical and non-clinical characteristics drive their decision-making in patients with geographic atrophy (GA). After the break, Dr. Faia shares a real-world case from her clinic in which a patient who was lost to follow-up returns to consider treatment.…

1
AMD and DME Applications in the Retina Practice: RCT Comparison 21:13

2M ago21:13

21:13

What conclusions can be drawn from a cross-trial comparison of randomized clinical trials assessing the safety and efficacy of anti-VEGF agents used in the treatment of AMD and DME? Paul Hahn, MD, PhD, sits down with Durga Borkar, MD, MMCi, and Ted Leng, MD, to review a recent presentation by Dr. Leng on this topic, and to examine the clinical rele…

1
Exploring the FDA 43:06

3M ago43:06

43:06

In this compelling OIS podcast episode, host Dr. Rob Rothman engages in an insightful conversation with Dr. Malvina Eydelman, the Director of the FDA's Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices. Delve into Malvina's unique career journey and discover how her diverse background in engineering and ophthalmology has influe…

1
The State of Biosimilars: Integration of Biosimilars into a Retina Practice 22:03

3M ago22:03

22:03

Biosimilars in retina are here. How are practices integrating them into their clinics? And how do they navigate issues around payer policy, protocol changes, and ensuring continuity of care? Moderator John Kitchens, MD, sits down with retina specialist Dave Brown, MD, and Kristin Yockus, the VP of Process Integrations at Retina Consultants of Ameri…

1
New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT 15:48

3M ago15:48

15:48

How do endophthalmitis rates after intravitreal injection differ after using povidone-iodine compared with chlorhexidine? Moderator Sruthi Arepalli, MD, hears from panelists Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH, about a recent peer-reviewed retrospective cohort study on this topic. After the break, the trio discuss how to manage patient…

1
Developing a Culture to Thrive and Prevent Burnout with Quinn McCullough at Scottsdale Detox Center and The Hope House 50:44

3M ago50:44

50:44

This is the Healthcare Executive Insights Podcast presented by The Macallan Group. In Episode 52, we sit down with Quinn Davidson, who shares the innovative approach of Scottdale Detox Center and The Hope House in tackling substance abuse. Their focus on individualized and comfortable care in a holistic, trauma-informed environment aims to address …

1
Improving Patient Care Through SOPs and Innovative Technologies with Kelly Ladd at Piedmont Internal Medicine 43:48

3M ago43:48

43:48

This is the Healthcare Executive Insights Podcast presented by The Macallan Group. In Episode 51, we speak with Kelly Ladd, CEO of Piedmont Internal Medicine. Kelly has extensive experience in healthcare management, particularly in private physician practices. She shares her journey and insights with us, highlighting the importance of adaptability …

1
Empathy in Action 43:51

3M ago43:51

43:51

In the latest episode of the OIS podcast, host Dr. Rob Rothman delves into the transformative power of empathy with multi-Emmy award-winning actress and writer, Ellen Gould. Together, they explore the intersection of healthcare and storytelling, shedding light on the importance of patient-centered care and authentic narrative representation. Episod…

1
Successful Management of Vitreous Opacities 25:38

3M ago25:38

25:38

Performing surgery for symptomatic vitreous opacities (SVO) was once verboten in retina medicine, but the field has seen a sea-change in mindset over the past decade. In this podcast, moderator John Kitchens, MD, is joined by Edwin H. Ryan, MD; Christina Y. Weng, MD, MBA; and Alison Bozung, OD, to explore why surgery for SVO has become more palatab…

1
From Ophthalmology Clinics to Business Leadership 51:23

4M ago51:23

51:23

In this episode, Dr. Jai Parekh shares his journey from ophthalmology to business leadership in healthcare. Raised in New Jersey, he initially pursued cardiology before discovering his passion for ophthalmology. Specializing in cornea and refractive surgery, he transitioned into the commercial side of the field, leveraging his clinical expertise an…

1
New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery 20:17

4M ago20:17

20:17

Do the status of the fovea and/or the timing of surgery affect visual outcomes following RRD repair? Join New Retina Radio Journal Club host Lediana Goduni, MD, as she and panelists Matt Starr, MD, and Joshua Uhr, MD, dissect the findings of a recent paper exploring this question. After the break, the trio discusses tactics for overcoming challenge…

1
ASRS Leaders and Legends Interview: Yale L. Fisher, MD 31:15

4M ago31:15

31:15

Dr. Yale Fisher has had an undeniable impact on the field of retina. He led the way in the development of new techniques and instruments in the field, particularly in ultrasonography and vitreoretinal surgery. His pioneering work in ocular endoscopy has expanded the boundaries of what is possible in the field and he has shared his expertise extensi…

1
Exploring the Future of Eye Care 38:31

4M ago38:31

38:31

Don't miss the latest episode of the OIS Retina Podcast, where we sit down with optometrist and ophthalmology researcher Brian Levy for an illuminating discussion on the future of eye care. In this episode, Brian takes us on a journey through his career, from his early days in vet school to his groundbreaking work at Presbyterian Medical Center, Ae…

1
Preserving a Legacy, Pioneering the Future: A CEO's Vision for Healthcare in South Carolina with William Kenley of AnMed 37:07

4M ago37:07

37:07

This is the Healthcare Executive Insights Podcast presented by The Macallan Group. In Episode 50, we speak with William Kenley, CEO of AnMed. In this episode, William discusses his vision for healthcare in South Carolina, emphasizing the importance of building on past success and expanding to meet the growing needs of the community. He highlights t…

1
5 Mistakes to Avoid in Biotech Investor Pitch Decks 18:32

5M ago18:32

18:32

Tune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top five mistakes to avoid when crafting your pitch deck and gain exclusive insights from Dr. Rothman's wealth o…

1
Treating Geographic Atrophy (GA) In Your Practice 17:47

5M ago17:47

17:47

Sponsored by Apellis Pharmaceuticals. Scott Walter, MD, and Esther Kim, MD, join John W. Kitchens, MD, to discuss how they treat GA in their practices. Listen to gain expert insights as Drs. Kim, Walter, and Kitchens each share their experiences with this treatment. They also share best practices for dosing based on trial data.…

1
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy 20:39

5M ago20:39

20:39

Sponsored by Apellis Pharmaceuticals. John W. Kitchens, MD, invites Scott Walter, MD, and Esther Kim, MD, to discuss best practices for identifying appropriate patients with GA for treatment. Gain perspectives on patient selection, patient education, and safety considerations.By Retina Today

1
The State of Biosimilars: How We Got Here and What It Means for Practice 25:19

5M ago25:19

25:19

Two biosimilars are approved for use in retina by the US FDA—and more will be approved in the coming years. What exactly are biosimilars? What benefit might they provide? And how confident are retina specialist that biosimilars will deliver safe, high-quality care? Moderator John Kitchens, MD, sits down with retina specialists Carl Awh, MD, and Fir…

1
ASRS Leaders and Legends Interview: Stuart L. Fine, MD 29:48

5M ago29:48

29:48

Dr. Stuart L. Fine is world-renowned for his leadership in ophthalmology education, research, and patient care. A pioneering investigator, Dr. Fine helped shape the field of retina through his leadership of numerous National Eye Institute (NEI)-supported, multi-centered clinical trials to evaluate new and existing treatments for retinal disease. Am…

1
Unlocking the Future of Presbyopia Treatment 19:32

5M ago19:32

19:32

Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation: Insider Insights: Dr. Karpecki shares insider insights gleaned from his extensive clinical experience and research in the fiel…

1
Cherchez la Femme Revisited 39:11

5M ago39:11

39:11

The field of retina has made significant strides when it comes to diversity, equity, and inclusion since Julia A. Haller, MD, penned her inspirational 2015 JAMA Ophthalmology editorial, Cherchez la Femme. The ever-growing body of research on this topic stands as a testament to her commitment to understanding the gaps in diversity, particularly in t…

Podcasts Worth a Listen

Retina Today Podcasts

Podcasts Worth a Listen

Quick Reference Guide